Systemic management of posterior uveitis

Journal of Ocular Pharmacology and Therapeutics

Volumn 19, Issue 4, 2003, Pages 325-343

  Song, Julia ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AZAPROPAZONE; AZATHIOPRINE; BROMOCRIPTINE; CIMETIDINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DANAZOL; DICLOFENAC; DILTIAZEM; FLUCONAZOLE; GENTAMICIN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; KETOCONAZOLE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; NICARDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RANITIDINE; SULFAMETHOXAZOLE; TOBRAMYCIN; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN; VERAPAMIL;

ALLERGY; ALOPECIA; ANEMIA; ARTICLE; BEHAVIOR DISORDER; CAPILLARY RESISTANCE; CHALAZION; CHEMOSIS; CONJUNCTIVAL HEMORRHAGE; CYSTITIS; DIABETES MELLITUS; DRUG ACTIVITY; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; EXOPHTHALMOS; FATIGUE; FRACTURE; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERPLASIA; GROWTH DISORDER; HEART ARRHYTHMIA; HEART INFARCTION; HEPATITIS; HERPES SIMPLEX; HIRSUTISM; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INSOMNIA; INTRAOCULAR HYPERTENSION; LEUKOPENIA; LIVER TOXICITY; LONG TERM CARE; LYMPHOCYTOPENIA; MALAISE; MOUTH ULCER; MYOPATHY; NAUSEA; NEPHROTOXICITY; OSTEOPOROSIS; PARESTHESIA; PATIENT MONITORING; PEPTIC ULCER; PHARYNGITIS; PTOSIS; RELAPSE; SHOCK; SIDE EFFECT; SINUSITIS; THROMBOCYTOPENIA; TREMOR; UVEITIS; WEIGHT GAIN; WOUND HEALING IMPAIRMENT;

DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MEDLINE; UNITED STATES; UVEITIS, POSTERIOR;

EID: 0041971229     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/108076803322279381     Document Type: Article

References (38)

1. Jabs, D.A., Rosenbaum, J.T., Foster, S., Holland, G.N., Jaffe, G.J., Louie, J.S., Nussenblatt, R.B., Stiehm, E.R., Tessler, H., Van Gelder, R.N., Whitcup, S.M., and Yocum, D. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel. Am. J. Ophthalmol. 130:492-513, 2000.
2. Lukert, B.P. Raisz, L.G. Glucocorticoid-induced osteoporosis. Rheum. Dis. Clinics of N. Am. 20:629-650, 1994.
3. nd ed., Mosby, St. Louis, 1996:99-102.
4. Hopper, P.L. and Kaplan, H.J. Triple agent immunosuppression in serpiginous choroiditis. Ophthalmology 98:944-952, 1991.
5. Morgan, C.M. and Schatz, H. Recurrent multi-focal choroiditis. Ophthalmol. 93:1138-1147, 1986.
6. Hayasaka, S., Okabe, H., and Takahashi, J. Systemic corticosteroid treatment in Vogt-Koyanagi-Harada disease. Graefe's Arch. Clin. Exp. Ophthalmol. 218:9-13, 1982.
7. Reed, J.B., Morse, L.S., and Schwab, I.R. High-dose intravenous pulse methylprednisolone hemisuccinaate in acute Behcet retinitis. Am. J. Ophthalmol. 125:409-411, 1998.
8. Polito, C., LaManna, A., Papale, M.R., and Villani, G. Delayed pubertal growth spurt and normal adult height attainment and boys receiving long-term alternate-day prednisone therapy. Clin. Pediatrics 38:279-285, 1999.
9. American College of Rheumatology Task Force on Osteoporosis Guidelines. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis & Rheumatism 39:1791-1801, 1996.
10. Zizic, T.M., Marcoux, C., Hungerford, D.S., Dansereau, J-V., and Stevens, M.B. Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am. J. Med. 79:596-603, 1985.
11. Moorthy, R.S., Rajeev, B., Smith, R.E., and Rao, N.A. Incidence and management of cataracts in Vogt-Koyanagi-Harada syndrome. Am. J. Ophthalmol. 118:197-204, 1994.
12. Aaberg, T.M., Cesarz, T.J., and Flickinger R.R. Treatment of pars planitis. Survey of Ophthalmol. 22:120-130, 1977.
13. Wallace, C.A. The use of methotrexate in childhood rheumatic diseases. Arthritis & Rheumatism 41:381-391, 1998.
14. Pascalis, L., Pia, G., Aresu, G., Frongia, T., and Barca, L. Combined cyclosporin A-Steroid-MTX treatment in endogenous non-infectious uveitis. J. of Autoimmunity 6:467-480, 1993.
15. Shah, S.S., Lowder, C.Y., Schmitt, M.A., Wilke, W.S., Kosmorsky, G.S., and Meisler, D.M. Low-dose methotrexate therapy for ocular inflammatory disease. Ophthalmology 99:1419-1423, 1992.
16. Foster, C.S., Forstot, S.L., and Wilson, L.A. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or periphral ulcerative keratitis. Ophthalmology 91:1253-1263, 1984.
17. Bermas, B.L., Hill, J.A. Effects of immunosuppressive drugs during pregnancy. Arthritis & Rheumatism 38:1722-1732, 1995.
18. Sandoval, dM., Alarcon, G.S., Morgan, S.L. Adverse events in methotrexate-treated rheumatoid arthritis patients. Br. J. Rheumatol. 4, Suppl. 2:49-56, 1995.
19. Nussenblatt, R.B., Palestine, A.G., and Chan, C. Cyclosporin A in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am. J. Ophthalmol. 96:275-282, 1983.
20. Nussenblatt, R.B., Palestine, A.G., Chan, C., Stevens, G., Mellow, S.D., and Green, S.B. Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis. Am. J. Ophthalmol. 112:138-146, 1991.
21. Nussenblatt, R.B., Palestine, A.G., and Chan, C. Cyclosporine therapy for uveitis: Long-term follow up. J. of Ocular Pharmacol. 1:369-382, 1985.
22. Nussenblatt, R.B., Palestine, A.G., Chan, C., Mochizuki, M., and Yancey, K. Effectiveness of cyclosporin therapy for Behcet's disease. Arthritis and Rheumatism 28:671-679, 1985.
23. Masuda, K., Urayama, A., Kogure, M., Nakajima, A., Nakae, K., and Inaba, G. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet's disease. Lancet 1:1093-1095, 1989.
24. BenEzra, D., Cohen, E., Chajek, T., Friedman, G., Pizanti, S., de Courten, C., and Harris, W. Evaluation of conventional therapy versus cyclosporine A in Behcet's syndrome. Transplantation Proceedings. 20, Suppl. 4:136-143, 1988.
25. Ozyazgan, Y., Yurdakul, S., Hazici, H., Tuzun, B., Iscimen, A., Tuzun, Y., Aktunc, T., Pazalri, H., Hamuryudan, V., and Muftuoglu, A. Low dose cyclosporin A versus pulsed cylcophosphamide in Behcet's syndrome: A single masked trial. Br. J. Ophthalmol. 76:241-243, 1992.
26. Elidan, J., Cohen, E., Levi, H., and BenEzra, D. Effect of cyclosporine A on the hearing loss in Behcet's disease. Ann. Otol. Rhinol. Laryngol. 100:464-468, 1991.
27. Seechi, A.G., Togno, M.S., Maselli, C. Cyclosporine-A in the treatment of serpiginous choroiditis. International Ophthalmol. 14:395-399, 1990.
28. Le Hoang, P., Girard, B., Deray, G., Minh, H.L., DeKozak, Y., Thillaye, B., Faure, J.P., and Rousselie, F. Cyclosporine in the treatment of birdshot retinochoroidopathy. Transplantation Proceedings 20, Suppl. 4:128-130, 1998.
29. Bielory, L., Holland, C., Gascon, P., and Frohman, L. Uveitis, cutaneous and neurosarcoid: Treatment with low-dose cyclosporine A. Transplantation Proceedings 20(Suppl. 4):144-148, 1998.
30. Walton, R.C., Nussenblatt, R.B., and Whitcup, S.M. Cyclosporin therapy for severe sight-threatening uveitis in children and adolescents. Ophthalmology 105:2028-2034, 1998.
31. Palestine, A.G., Austin, H.A., Balow, J.E., Antonovych, T.T., Sabnis, S.G., Preuss, H.G., and Nussenblatt R.B. Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N. Engl. J. of Med. 314:1293-1298, 1986.
32. Vitale, A.T., Rodriguez, A., and Foster, C.S. Low-dose cyclosporine therapy in the treatment of birdshot retinochorodiopathy. Ophthalmology 101:822-831, 1994.
33. Tugwell, P., Pincus, T., Yocum, D., Stein, M., Gluck, O., Kraag, G., McKendy, R., Tesser, J., Baker, P., and Wells, G. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N. Engl. J. of Med. 333:137-141, 1995.
34. Connell, W.R., Kamm, M.A., Dickson, A., Balkwill, A.M., Ritchie, J.K., and Lennard-Jones, J.E. Long-term neoplasm risk after azathioprine treatment in inflammatory bowel disease. Lancet 343:1249-1252, 1995.
35. Calin, A. A placebo controlled, crossover study of azathioproine in Reiter's syndrome. Ann. of Rheum. Dis. 45:653-655, 1986.
36. Yazici, H., Pazarli, H., Barnes, C.G., Tuzun, Y., Ozyazgan, Y., Silrman, A., Serdaroglu, S., Oguz, V., Yurdakul, S., Lovatt, G.E., Yazici, B., Somani, S., and Muftuoglu, A. A Controlled Trial of Azathioprine in Behcet's syndrome. New Engl. J. of Med. 332:281-285, 1990.
37. Newell, F.W., Krill, A.E. Treatment of uveitis with azathioprine (Imuran). Arch. of Ophthalmol. 499-511, 1966.
38. Andrasch, R.H., Pirofsky, B., and Burns, R.P. Immunosuppressive therapy for severe chronic uveitis. Arch. Ophthalmol. 96:247-285, 1978.